EP3348553
Kristölluð form af andrógenviðtakastilli
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
4.6.2013EP published:
8.7.2020EP application number:
18157435.1
EP translation filed:
28.7.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
3.6.2033Expiry date:
3.6.2025
Title:
CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR
Timeline
Today
4.6.2013EP application
8.7.2020EP Publication
28.7.2020Translation submitted
15.8.2020Registration published
3.6.2025Expires
Owner
Name:
Aragon Pharmaceuticals, Inc.Address:
10990 Wilshire Blvd. Suite 300, Los Angeles, CA 90024, US
Name:
Sloan-Kettering Institute for Cancer ResearchAddress:
1275 York Avenue, New York, NY 10065, US
Inventor
Name:
DILHAS, AnnaAddress:
4055 Basel, CH
Name:
OUERFELLI, OuathekAddress:
Fort Lee, NJ 07024, US
Name:
SMITH, Nicholas D.Address:
San Diego, CA 92109, US
Name:
HERBERT, Mark R.Address:
San Diego, CA 92111, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261656888 PDate:
7.6.2012Country:
US
Classification
Categories:
C07D 401/04, A61K 31/4439, A61K 31/4184, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 11.5.2021
Expires: 3.6.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 6.5.2022
Expires: 3.6.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 24.5.2023
Expires: 3.6.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.5.2024
Expires: 3.6.2025
Payer: Árnason Faktor ehf.